Tactile Systems Technology, Inc.
TCMD
$13.07
-$0.56-4.11%
| Weiss Ratings | TCMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Reward Grade | C+ | |||
| Rating Factors | TCMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Fair | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | TCMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.25 | |||
| Price History | TCMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -2.32% | |||
| 30-Day Total Return | -13.16% | |||
| 60-Day Total Return | -25.31% | |||
| 90-Day Total Return | -18.01% | |||
| Year to Date Total Return | -23.66% | |||
| 1-Year Total Return | -14.30% | |||
| 2-Year Total Return | -23.92% | |||
| 3-Year Total Return | -36.15% | |||
| 5-Year Total Return | -66.10% | |||
| 52-Week High % Change | -35.40% | |||
| 52-Week Low % Change | 22.57% | |||
| Price | TCMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $21.10 | |||
| 52-Week Low Price | $11.12 | |||
| 52-Week Low Price (Date) | Jul 05, 2024 | |||
| 52-Week High Price (Date) | Nov 26, 2024 | |||
| Valuation | TCMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 321.47M | |||
| Enterprise Value | 272.21M | |||
| Price/Earnings (TTM) | 19.70 | |||
| Earnings Per Share (TTM) | 0.69 | |||
| Earnings Per Share Growth | -42.04% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.14 | |||
| Price/Book (Q) | 1.50 | |||
| Enterprise Value/Revenue (TTM) | 0.93 | |||
| Price | $13.07 | |||
| Enterprise Value/EBITDA (TTM) | 9.40 | |||
| Enterprise Value/EBIT | 12.27 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | TCMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 24.47M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | TCMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 612 355 5100 | |||
| Address | 3701 Wayzata Boulevard Minneapolis, MN 55416 | |||
| Website | tactilemedical.com | |||
| Country | United States | |||
| Year Founded | 1995 | |||
| Profitability | TCMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 7.57% | |||
| Profit Margin | 5.78% | |||
| Management Effectiveness | TCMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 4.79% | |||
| Return on Equity | 8.27% | |||
| Income Statement | TCMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 292.98M | |||
| Total Revenue (TTM) | 292.98M | |||
| Revenue Per Share | $11.97 | |||
| Gross Profit (TTM) | 216.69M | |||
| EBITDA (TTM) | 28.97M | |||
| EBIT (TTM) | 22.18M | |||
| Net Income (TTM) | 16.96M | |||
| Net Income Avl. to Common (TTM) | 16.96M | |||
| Total Revenue Growth (Q YOY) | 10.22% | |||
| Earnings Growth (Q YOY) | 18.46% | |||
| EPS Diluted (TTM) | 0.69 | |||
| EPS Diluted Growth (Q YOY) | 13.53% | |||
| Balance Sheet | TCMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 94.37M | |||
| Cash Per Share (Q) | $3.86 | |||
| Total Current Assets (Q) | 177.56M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 216.60M | |||
| Current Ratio (Q) | 4.362 | |||
| Book Value Per Share (Q) | $9.07 | |||
| Total Assets (Q) | 297.92M | |||
| Total Current Liabilities (Q) | 40.70M | |||
| Total Debt (Q) | 45.11M | |||
| Total Liabilities (Q) | 81.33M | |||
| Total Common Equity (Q) | 216.60M | |||
| Cash Flow | TCMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -2.50M | |||
| Cash from Financing (TTM) | -4.82M | |||
| Net Change in Cash (TTM) | 33.33M | |||
| Levered Free Cash Flow (TTM) | 25.20M | |||
| Cash from Operations (TTM) | 40.66M | |||
